10 research outputs found

    Efeitos da administração a longo prazo de dietas com diferentes teores de sódio sobre a função renal de ratos hipertensos

    Get PDF
    A alta ingestão de sódio contribui significativamente para o desenvolvimento da hipertensão e suas complicações. Dentre estas, a doença renal crônica. Entretanto, os mecanismos moleculares responsáveis pelos danos renais e pela renoproteção produzidos por dietas de alto e baixo sal, respectivamente, são pouco compreendidos. Objetivo: Investigar os efeitos a longo prazo de dietas com diferentes teores de cloreto de sódio sobre a função renal de ratos espontaneamente hipertensos (SHR) focando nos mecanismos moleculares envolvidos no manejo renal de albumina e componentes do sistema renina angiotensina renal (SRA). Métodos: ratos SHR machos recém-desmamados (4 semamas) foram alimentados durante 6 meses com dietas diferindo apenas no teor de NaCl: dieta padrão de sal (NS: 0.3 %), dieta de baixo sal (LS: 0.03%) e dieta de alto teor de sal ( HS: 3%). Foram realizadas análises de função e morfologia renal, avaliação da expressão de componentes-chave envolvidos no manejo renal de albumina, incluindo as proteínas da slit membrane (nefrina e podocina) e do aparato endocítico do túbulo proximal (megalina e cubilina). Além disso, a expressão ea atividade dos componentes do RAS (enzima conversora de angiotensina ACE, ACE2, AT1, AT2 e Mas) também foram examinados. Resultados: HS agravou a hipertensão nos ratos SHR, provocou hipertrofia glomerular, diminuição da expressão renal de nefrina e ECA2, levou à perda da integridade morfológica dos processos podais e ao aumento da proteinúria caracterizado pela perda de albumina e proteínas de alto peso molecular. Por outro lado, a hipertensão grave foi atenuada e disfunção renal foi prevenida pela dieta LS, já que, a proteinúria foi muito menor nestes animais quando comparados aos SHR NS. Tais achados foram associados com uma diminuição da razão de proteína e de atividade das enzimas ECA/ECA2 nos rins e aumento da expressão renal de cubilina. Conclusão: Portanto, os resultados sugerem que a dieta a baixa ingestão de sódio atenua a progressão da hipertensão em ratos SHR e preserva a função renal. Os mecanismo que parcialmente podem explicar estes resultados incluem a modulação intra-renal do balanço ECA/ECA2 e o aumento da expressão renal de cubilina. Contudo, a alta ingestão de sódio agrava a lesão renal hipertensiva e reduz a expressão de nefrina, um componente chave slit diaphragm

    Egyptian glycogen storage disease type III – identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId

    Get PDF
    Background: Glycogen storage disease type III (GSD III) is caused by mutations in AGL which encodes for a single protein with two enzyme activities: oligo-1, 4-1, 4-glucantransferase (transferase) and amylo-1, 6-glucosidase. Activity of both enzymes is lost in most patients with GSD III, but in the very rare subtype IIId, transferase activity is deficient. Since the spectrum of AGL mutations is dependent on the ethnic group, we investigated the clinical and molecular characteristics in Egyptian patients with GSD III. Methods: Clinical features were examined in five Egyptian patients. AGL was sequenced and AGL haplotypes were determined. Results: Six novel AGL mutations were identified: a large deletion (c.3481–3588+1417del1525 bp), two insertions (c.1389insG and c.2368insA), two small deletions (c.2223–2224delGT and c.4041delT), and a missense mutation (p.L620P). p.L620P was found in a patient with IIId. Each mutation was located on a different AGL haplotype. Conclusions: Our results suggest that there is allelic and phenotypic heterogeneity of GSD III in Egypt. This is the second description of a large deletion in AGL. p.L620P is the second mutation found in GSD IIId. Clin Chem Lab Med 2009;47:1233–8.Peer Reviewe

    Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations.

    No full text
    Glycogen storage disease type III (GSD III) is an autosomal recessive disorder caused by deficiency in the glycogen debranching enzyme (gene symbol: AGL) with two enzyme activities: transferase and glucosidase. A missense mutation causing isolated glucosidase deficiency has never been reported. In this study, we examined 23 patients of Turkish ancestry and identified a novel missense mutation p.R1147G with isolated glucosidase deficiency, along with nine AGL mutations: six nonsense mutations (p.W373X, p.R595X, p.Q667X, p.Q1205X, p.W1327X and p.Q1376X), one deletion (c.1019delA) and two splicing mutation (c.293+2T > G and c.958+1G > A). As p.R1147G impaired glucosidase activity, but maintained transferase activity in vitro, a 12-year-old girl homozygous for p.R1147G was diagnosed with having isolated glucosidase deficiency. Of nine other mutations, p.W1327X and c.1019delA were recurrent, whereas seven mutations were novel. Six patients with p.W1327X were all from two nearby cities on the East Black Sea and shared the same AGL haplotype, indicating a founder effect in Turkish patients. Patients with the same mutations had identical haplotypes. Our results provide the first comprehensive overview of clinical and molecular features of Turkish GSD III patients and the first description of the missense mutation associated with isolated glucosidase deficiency. Journal of Human Genetics (2009) 54, 681-686; doi:10.1038/jhg.2009.100; published online 16 October 200

    Multiple phenotypes in phosphoglucomutase 1 deficiency.

    Get PDF
    Congenital disorders of glycosylation are genetic syndromes that result in impaired glycoprotein production. We evaluated patients who had a novel recessive disorder of glycosylation, with a range of clinical manifestations that included hepatopathy, bifid uvula, malignant hyperthermia, hypogonadotropic hypogonadism, growth retardation, hypoglycemia, myopathy, dilated cardiomyopathy, and cardiac arrest
    corecore